Shenzhen New Industries Biomedical (300832) — Net Asset Quality Index
Shenzhen New Industries Biomedical (300832) has a Net Asset Quality Index of 91.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.58 Billion minus total liabilities of CN¥831.98 Million yields net assets of CN¥8.74 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 300832 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shenzhen New Industries Biomedical Net Asset Quality Index Over Time (2012–2024)
This chart shows how Shenzhen New Industries Biomedical's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 91.3%, representing net assets of CN¥8.74 Billion against total assets of CN¥9.58 Billion CNY. See 300832 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shenzhen New Industries Biomedical (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Shenzhen New Industries Biomedical from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shenzhen New Industries Biomedical (300832) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.2% | CN¥8.58 Billion | CN¥9.62 Billion | CN¥1.04 Billion | ▼ -2.6 pp |
| 2023 | 91.8% | CN¥7.54 Billion | CN¥8.22 Billion | CN¥678.09 Million | ▲ +0.5 pp |
| 2022 | 91.2% | CN¥6.40 Billion | CN¥7.01 Billion | CN¥615.06 Million | ▼ -0.2 pp |
| 2021 | 91.5% | CN¥5.61 Billion | CN¥6.14 Billion | CN¥523.51 Million | ▲ +0.9 pp |
| 2020 | 90.5% | CN¥4.80 Billion | CN¥5.31 Billion | CN¥501.49 Million | ▼ -0.2 pp |
| 2019 | 90.8% | CN¥3.14 Billion | CN¥3.46 Billion | CN¥318.92 Million | ▲ +1.2 pp |
| 2018 | 89.6% | CN¥2.37 Billion | CN¥2.64 Billion | CN¥274.52 Million | ▲ +2.0 pp |
| 2017 | 87.6% | CN¥1.77 Billion | CN¥2.02 Billion | CN¥250.00 Million | ▼ -0.8 pp |
| 2016 | 88.4% | CN¥1.42 Billion | CN¥1.61 Billion | CN¥185.75 Million | ▼ -0.7 pp |
| 2015 | 89.1% | CN¥1.02 Billion | CN¥1.15 Billion | CN¥124.94 Million | ▲ +7.2 pp |
| 2014 | 81.9% | CN¥610.52 Million | CN¥745.44 Million | CN¥134.92 Million | ▲ +11.9 pp |
| 2013 | 70.0% | CN¥378.84 Million | CN¥540.96 Million | CN¥162.12 Million | ▼ -9.2 pp |
| 2012 | 79.3% | CN¥248.18 Million | CN¥313.11 Million | CN¥64.93 Million | — |